These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3372544)

  • 1. Studies on yellow fever vaccine. II--Stability of the reconstituted product.
    Lopes Ode S; Guimarães SS; de Carvalho R
    J Biol Stand; 1988 Apr; 16(2):71-6. PubMed ID: 3372544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thermal stability of yellow fever vaccines.
    Ishak R; Howard CR
    Mem Inst Oswaldo Cruz; 1990; 85(3):339-45. PubMed ID: 2134708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on yellow fever vaccine. III--Dose response in volunteers.
    Lopes Ode S; Guimarães SS; de Carvalho R
    J Biol Stand; 1988 Apr; 16(2):77-82. PubMed ID: 3372545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-related studies on 17D yellow fever vaccine.
    Perraut R; Girault G; Moreau JP
    Microbes Infect; 2000 Jan; 2(1):33-8. PubMed ID: 10717538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of an improved experimental yellow fever vaccine.
    Tannock GA; Wark MC; Hair CG
    J Biol Stand; 1980; 8(1):23-34. PubMed ID: 7400156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stability of a new thermostable 17D yellow fever vaccine].
    Durand JP; Kollo B; Merlin M; Le Hesran JY; Josse R; Garrigue GP
    J Biol Stand; 1988 Jan; 16(1):1-7. PubMed ID: 3350820
    [No Abstract]   [Full Text] [Related]  

  • 9. [The quality standardization of a national vaccine against yellow fever].
    Rasshchepkina MN; Levina VD; Vorob'eva MS; Kozlov VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):47-50. PubMed ID: 2251891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
    Finter NB; Burfoot C; Young PA; Ferris R
    Dev Biol Stand; 1976 Oct; 36():279-83. PubMed ID: 1030425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid test for measuring the infectivity of Yellow Fever vaccine.
    Sood DK; Aggarwal RK; Kumar S; Sokhey J
    Vaccine; 1995 Apr; 13(5):427-8. PubMed ID: 7639009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
    Georges AJ; Tible F; Meunier DM; Gonzalez JP; Beraud AM; Sissoko-Dybdahl NR; Abdul-Wahid S; Fritzell B; Girard M; Georges-Courbot MC
    Vaccine; 1985 Sep; 3(3):313-5. PubMed ID: 4060841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thermal stability of a stabilized 17D yellow fever virus vaccine.
    Burfoot C; Young PA; Finter NB
    J Biol Stand; 1977; 5(3):173-9. PubMed ID: 893463
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
    Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
    Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined vaccination against yellow fever and typhoid fever: a comparative trial.
    Ambrosch F; Fritzell B; Gregor J; Jonas S; Kollaritsch H; Teulieres L; Wiedermann G
    Vaccine; 1994 May; 12(7):625-8. PubMed ID: 8085380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.
    Monath TP; Kinney RM; Schlesinger JJ; Brandriss MW; Brès P
    J Gen Virol; 1983 Mar; 64 Pt 3():627-37. PubMed ID: 6298349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.